Placebo, N = 24 | ACEMg, N = 25 | Total, N = 49 | |
---|---|---|---|
Sex | |||
Male | 9 (37.5%) | 10 (40.0%) | 19 (38.8%) |
Female | 15 (62.5%) | 15 (60.0%) | 30 (61.2%) |
p value (χ2) | 0.8575 | ||
Age | |||
N | 24 | 25 | 49 |
Mean | 57.38 | 53.64 | 55.47 |
STD | 9.37 | 16.85 | 13.70 |
Mean difference | 3.74 | ||
p value (t test) | 0.3413 | ||
Treated ear | |||
Left | 7 (29.2%) | 11 (44.0%) | 18 (36.7%) |
Right | 17 (70.8%) | 14 (56.0%) | 31 (63.3%) |
p value (χ2) | 0.2816 | ||
Used electrode length | |||
Flex 20 | 4 (16.7%) | 3 (12.0%) | 7 (14.3%) |
Flex 24 | 4 (16.7%) | 6 (24.0%) | 10 (20.4%) |
Flex 28 | 16 (66.7%) | 16 (64.0%) | 32 (65.3%) |
p value (χ2) | 0.7700 | ||
Surgeon | |||
Surgeon 1 | 2 (8.3%) | 1 (4.0%) | 3 (6.1%) |
Surgeon 2 | 13 (54.2%) | 16 (64.0%) | 29 (59.2%) |
Surgeon 3 | 2 (8.3%) | 0 (0.0%) | 2 (4.1%) |
Surgeon 4 | 2 (8.3%) | 3 (12.0%) | 5 (10.2%) |
Surgeon 7 | 1 (4.2%) | 2 (8.0%) | 3 (6.1%) |
Surgeon 9 | 1 (4.2%) | 0 (0.0%) | 1 (2.0%) |
Surgeon 10 | 1 (4.2%) | 3 (12.0%) | 4 (8.2%) |
Surgeon 11 | 1 (4.2%) | 0 (0.0%) | 1 (2.0%) |
Surgeon 12 | 1 (4.2%) | 0 (0.0%) | 1 (2.0%) |
p value (χ2) | 0.5195 | ||
Surgeon (categorized) | |||
Surgeon 2 | 13 (54.2%) | 16 (64.0%) | 29 (59.2%) |
Other surgeons | 11 (45.8%) | 9 (36.0%) | 20 (40.8%) |
p value (χ2) | 0.4839 |